YD Bio Ltd (YDES)
NASDAQ (NGS) NASDAQ (NGS) Primary Summary
YD Bio Ltd (YDES) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has YD Bio Ltd ever had a stock split?
YD Bio Ltd Profile
| Biotechnology Industry | Healthcare Sector | Ethan Shen CEO | NASDAQ (NGS) Exchange | G98301107 CUSIP |
| TW Country | 4 Employees | - Last Dividend | - Last Split | - IPO Date |
Overview
YD Bio Ltd. is a pioneering biotechnology company dedicated to the development of advanced detection and therapeutic technologies. Founded on February 6, 2024, the company is based in Taipei, Taiwan. YD Bio aims to enhance healthcare outcomes through innovative solutions, focusing on critical areas such as cancer detection, regenerative ophthalmology, and exosome science. With a commitment to research and development, the company is positioning itself at the forefront of medical technology.
Products and Services
- Cancer Detection Products
YD Bio offers a range of advanced cancer detection products designed to identify various types of cancer at early stages. Utilising state-of-the-art biomarkers and diagnostic technologies, these products aim to improve the accuracy of cancer screenings and facilitate timely interventions for better patient outcomes.
- Regenerative Ophthalmology Products
The company develops regenerative ophthalmology products that focus on repairing and restoring vision. Leveraging cutting-edge research in tissue regeneration and cell therapy, these products aim to treat eye diseases and conditions, enhancing quality of life for patients suffering from vision impairments.
- Exosome Science
YD Bio delves into exosome science, which explores the role of exosomes in cell communication and disease progression. Through innovative research, YD Bio is working on harnessing the potential of exosomes for therapeutic applications, including their use in drug delivery and as biomarkers for various diseases.
